Co-administration of Chrysin and Luteolin with Cisplatin and Topotecan Exhibits a Variable Therapeutic Value in Human Cancer Cells, HeLa

[Image: see text] Combinational treatment is a promising strategy for better cancer treatment outcomes. Chrysin and luteolin have demonstrated effective anticancer activity. Cisplatin and topotecan are commonly used for the treatment of human cancers. However, various side effects including drug res...

Descripción completa

Detalles Bibliográficos
Autores principales: Raina, Ritu, Hussain, Arif, Almutary, Abdulmajeed G., Haque, Shafiul, Raza, Tasleem, D’Souza, Ashley Cletus, Subramani, Sachin, Sajeevan, Akash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633856/
https://www.ncbi.nlm.nih.gov/pubmed/37970041
http://dx.doi.org/10.1021/acsomega.3c04443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633856/
https://www.ncbi.nlm.nih.gov/pubmed/37970041
http://dx.doi.org/10.1021/acsomega.3c04443

Ejemplares similares